Skip to content

A Study Looking at Women's Experiences After a Miscarriage

An Investigation of Women's Experiences Following Karyotyping Products of Conception After a Miscarriage

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01223482
Enrollment
400
Registered
2010-10-19
Start date
2010-10-31
Completion date
2011-06-30
Last updated
2010-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Miscarriage

Keywords

Miscarriage, Karyotyping, Genetic testing

Brief summary

Studies have shown that a majority of pregnancies that end in miscarriage are due to a chromosome abnormality usually involving a duplicated or missing chromosome. Often this happens by chance and is not likely to occur in future pregnancies. For many women, a miscarriage can be a traumatic experience and can cause feelings of loss and grief. The option of genetic testing, such as karyotyping, may offer an explanation for the miscarriage and may help some women find closure in their loss. However, no literature exists on a women's experience with genetic testing following a miscarriage. This assumption that the knowledge that can be gained from karyotyping may be a positive experience for a woman following a miscarriage should be studied and the results published. This study will address whether routine karyotyping should be offered following a miscarriage for the purpose of benefiting the patient's experience.

Interventions

None listed

Sponsors

Stanford University
CollaboratorOTHER
California State University, Stanislaus
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* The inclusion criteria for this project will be females, 18 years or older, of any ethnicity that have had a 1st trimester miscarriage within the last one year, who currently reside in the US and have done so for the past one year.

Exclusion criteria

*

Countries

United States

Contacts

Primary ContactDiem T Huynh, B.S.
diem218@gmail.com650-483-5827

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026